23 May 2013
Keywords: Canada, Pharma economic impact, R&D investment, Rx&D, Clinical trials
Article | 23 October 2012
Three new reports released by Canada’s Research-Based Pharmaceutical Companies (Rx&D) provide a combined snapshot of the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 October 2012
© 2013 thepharmaletter.com